Go Back to Match Results for ""

Immunomodulatory effects of IL-33 in atopic dermatitis
Study Overview
The purpose of this study is to define the effects of neutralizing a certain protein affecting healthy and diseased skin and blood from patients with atopic dermatitis and to determine if the response to neutralization will differ between different subtypes of atopic dermatitis
Study Description
The purpose of this study is to define the effects of neutralizing a certain protein (IL-33) affecting healthy and diseased skin and blood from patients with atopic dermatitis and to determine if the response to neutralization will differ between different subtypes of atopic dermatitis.
Additional Information
- IRB Number: 1508749599
- Research Study Identifier: TX5515
- Principal Investigator: Matthew Turner, MD
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required